What is the clinical evidence from this study?

Population: Essential hypertension (n=28). Intervention: Indomethacin vs. Basal conditions (no indomethacin). Primary outcome: Maximum forearm blood flow increase to acetylcholine (p=< .01).

What question did this study set out to answer?

This research investigates the impact of cyclooxygenase inhibition on nitric oxide-mediated vasodilation in individuals with essential hypertension.

January 1, 1997HypertensionOpen Access

Cyclooxygenase Inhibition Restores Nitric Oxide Activity in Essential Hypertension

Q: What are the key findings of this study?

Cyclooxygenase inhibition with indomethacin restored nitric oxide-mediated vasodilation to acetylcholine in essential hypertensive patients (maximum flow increase 635% vs 458%; P<0.01).

Q: What question did this study set out to answer?

This research investigates the impact of cyclooxygenase inhibition on nitric oxide-mediated vasodilation in individuals with essential hypertension.

View Full Paper

Ask AI

Bookmark

Key result

Cyclooxygenase inhibition with indomethacin restored nitric oxide-mediated vasodilation to acetylcholine in essential hypertensive patients (maximum flow increase 635% vs 458%; P<0.01).

Why the study?

Does cyclooxygenase inhibition restore nitric oxide-mediated vasodilation in patients with essential hypertension?

Key Points

This research investigates the impact of cyclooxygenase inhibition on nitric oxide-mediated vasodilation in individuals with essential hypertension.
Participants included seven normotensive and seven essential hypertensive subjects, testing forearm blood flow response to intrabrachial acetylcholine with and without COX and NOS inhibitors.
Vasodilation responses were measured using strain-gauge plethysmography under various conditions: indomethacin (COX inhibitor) and L-NMMA (NOS inhibitor).
An adjunctive analysis was performed with L-arginine to evaluate NO synthase substrate effects in the same groups.
In hypertensive patients, indomethacin significantly increased acetylcholine-induced vasodilation (maximum flow increase: 635 +/- 53%; P < .01).
Indomethacin restored the inhibitory effect of L-NMMA in hypertensives (maximum flow increase: 445 +/- 36%; P < .01).
In the follow-up with L-arginine, indomethacin again enhanced vasodilation in hypertensives (maximum flow increase: 592 +/- 38%; P < .01).

Structured PICO

Does cyclooxygenase inhibition restore nitric oxide-mediated vasodilation in patients with essential hypertension?

Population

28 subjects (14 normotensive and 14 with essential hypertension) undergoing forearm blood flow evaluation with intrabrachial infusions.

Intervention

Intrabrachial infusion of acetylcholine in combination with L-NMMA (nitric oxide synthase inhibitor), indomethacin (cyclooxygenase inhibitor), or L-arginine (NO synthase substrate).

Comparator

Basal conditions (acetylcholine alone) and normotensive control subjects.

Outcome

Forearm blood flow modifications measured by strain-gauge plethysmography.surrogate

Main Result

Absolute Event Rate: 635% vs 458%

p-value: p=< .01

Cyclooxygenase inhibition with indomethacin restores nitric oxide-mediated vasodilation in essential hypertension, suggesting that COX-dependent constrictors impair NO production.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

COX inhibition may modulate endothelial dysfunction in hypertension; leaves open clinical relevance and needs prospective validation.

Cite This Study

Taddei et al. (1997) studied Essential hypertension (n=28). Indomethacin vs. Basal conditions (no indomethacin) was evaluated on Maximum forearm blood flow increase to acetylcholine (p=< .01). Cyclooxygenase inhibition with indomethacin restored nitric oxide-mediated vasodilation to acetylcholine in essential hypertensive patients (maximum flow increase 635% vs 458%; P<0.01).

synapsesocial.com/papers/6a22489321b01fc9abab4d1d https://doi.org/10.1161/01.hyp.29.1.274

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Cyclooxygenase Inhibition Restores Nitric Oxide Activity in Essential Hypertension

Key Points

Structured PICO

Main Result

Discussion

Implication

Cite This Study

Topics

Cyclooxygenase Inhibition Restores Nitric Oxide Activity in Essential Hypertension

Key Points

Structured PICO

Main Result

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider